本页面由Tiger Trade Technology Pte. Ltd.提供服务

Bolt Biotherapeutics, Inc.

4.24
+0.13003.16%
盘后:4.240.00000.00%16:00 EDT
成交量:2.87万
成交额:12.52万
市值:813.84万
市盈率:-0.26
高:4.68
开:4.13
低:4.13
收:4.11
52周最高:7.20
52周最低:3.10
股本:191.94万
流通股本:144.06万
量比:0.78
换手率:1.99%
股息:- -
股息率:- -
每股收益(TTM):-16.3353
每股收益(LYR):-17.8500
净资产收益率:-111.65%
总资产收益率:-30.73%
市净率:0.64
市盈率(LYR):-0.24

数据加载中...

2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/10

重要事件披露

Form 8-K - Current report
2023/08/07

重要事件披露

Form 8-K - Current report
2023/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/14

重要事件披露

Form 8-K - Current report
2023/05/11

重要事件披露

8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/29

重要事件披露

8-K - Current report
2023/03/29

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/29

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/04

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/14

重要事件披露

8-K - Current report
2022/11/10

重要事件披露

8-K - Current report